These researchers speculated that bile acids played an immunomodulatory role by activating Farnesoid X receptor (FXR) and other receptors and decreased the activity of bile salt hydrolase in IBD patients, resulting in an imbalance between primary and secondary bile acids (Gadaleta et al., 2011). Here, NR1H4 is linked to inflammatory bowel disease.